Welcome to the Office of Cancer Survivorship Program, DCCPS

The NCI Office of Cancer Survivorship (OCS) works to enhance the quality and length of survival of all persons diagnosed with cancer and to prevent, minimize, or manage adverse effects of cancer and its treatment.


Dr. Emily Tonorezos

Meet the new OCS director, 
Dr. Emily S. Tonorezos.

 

Spotlight

Publication

March. 2021 — Disparities and Barriers to Pediatric Cancer Survivorship Care

This AHRQ Technical Brief was commissioned by NCI to support the development of a research agenda associated with the Childhood Cancer Survivorship, Treatment, Access, and Research (STAR) Act.

Feature

Feb. 2021 — Request for Information (RFI)

Leveraging clinical trial populations in NCI’s national clinical trial network (NCTN) and community oncology research program (NCORP) for observational cancer survivorship studies.

Blog

Feb. 2021 — Cancer Currents Blog

Coronavirus Vaccines and People with Cancer: A Q&A with Dr. Steven Pergam.

Blog

Feb. 2021 — Cancer Currents Blog

Rate of suicides related to cancer is declining.

View More News and Highlights

About The Office of Cancer Survivorship

An individual is considered a cancer survivor from the time of diagnosis, through the balance of his or her life. There are many types of survivors, including those living with cancer and those free of cancer. This term is meant to capture a population of those with a history of cancer rather than to provide a label that may or may not resonate with individuals.

OCS works to promote a better understanding of unique needs of the growing population of cancer survivors, and to enhance our ability to address them.

Quick Links